HK1013999A1 - Quinolone derivative for treatment of urinary incontinence - Google Patents

Quinolone derivative for treatment of urinary incontinence

Info

Publication number
HK1013999A1
HK1013999A1 HK98115420A HK98115420A HK1013999A1 HK 1013999 A1 HK1013999 A1 HK 1013999A1 HK 98115420 A HK98115420 A HK 98115420A HK 98115420 A HK98115420 A HK 98115420A HK 1013999 A1 HK1013999 A1 HK 1013999A1
Authority
HK
Hong Kong
Prior art keywords
urinary incontinence
treatment
quinolone derivative
quinolone
derivative
Prior art date
Application number
HK98115420A
Other languages
English (en)
Inventor
John Edward Warawa
Cyrus John Ohnmacht
Diane Amy Trainor
James Michael Hulsizer
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of HK1013999A1 publication Critical patent/HK1013999A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK98115420A 1994-04-14 1998-12-24 Quinolone derivative for treatment of urinary incontinence HK1013999A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9407432A GB9407432D0 (en) 1994-04-14 1994-04-14 Heterocyclic derivative
PCT/GB1995/000845 WO1995028388A1 (en) 1994-04-14 1995-04-13 Quinolone derivative for treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
HK1013999A1 true HK1013999A1 (en) 1999-09-17

Family

ID=10753541

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98115420A HK1013999A1 (en) 1994-04-14 1998-12-24 Quinolone derivative for treatment of urinary incontinence

Country Status (25)

Country Link
EP (1) EP0755382B1 (xx)
JP (1) JP3782445B2 (xx)
KR (1) KR100344885B1 (xx)
CN (1) CN1058708C (xx)
AT (1) ATE202089T1 (xx)
AU (1) AU700773B2 (xx)
BR (1) BR9507366A (xx)
CA (1) CA2187525C (xx)
CZ (1) CZ284652B6 (xx)
DE (1) DE69521310T2 (xx)
DK (1) DK0755382T3 (xx)
ES (1) ES2159633T3 (xx)
FI (2) FI114705B (xx)
GB (1) GB9407432D0 (xx)
GR (1) GR3036482T3 (xx)
HK (1) HK1013999A1 (xx)
HU (1) HU215387B (xx)
MX (1) MX9603920A (xx)
NO (1) NO307177B1 (xx)
NZ (1) NZ283779A (xx)
PL (2) PL183095B1 (xx)
PT (1) PT755382E (xx)
RU (1) RU2149870C1 (xx)
SK (1) SK281124B6 (xx)
WO (1) WO1995028388A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60036476T2 (de) * 1999-08-03 2008-06-12 Abbott Laboratories, Abbott Park Kalium kanalaktivatoren
EP1307429B1 (en) * 2000-08-02 2007-11-28 AstraZeneca AB Process for asymmetric synthesis of substituted 1,4-dihydropyridines
SE0200205D0 (sv) * 2002-01-24 2002-01-24 Astrazeneca Ab Method
CN102532015B (zh) * 2012-01-18 2013-10-23 云南大学 香豆素及其类似物的固相合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
GB9220570D0 (en) * 1991-10-21 1992-11-11 Ici Plc Therapeutic agent
GB9318935D0 (en) * 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives

Also Published As

Publication number Publication date
NO307177B1 (no) 2000-02-21
CA2187525C (en) 2006-01-24
DE69521310D1 (de) 2001-07-19
FI20040352A (fi) 2004-03-04
PL182031B1 (pl) 2001-10-31
KR100344885B1 (ko) 2002-11-30
GB9407432D0 (en) 1994-06-08
JPH09512254A (ja) 1997-12-09
EP0755382A1 (en) 1997-01-29
DK0755382T3 (da) 2001-09-10
PL183095B1 (pl) 2002-05-31
PL316790A1 (en) 1997-02-17
GR3036482T3 (en) 2001-11-30
CN1146202A (zh) 1997-03-26
SK281124B6 (sk) 2000-12-11
HUT76132A (en) 1997-06-30
BR9507366A (pt) 1997-09-23
FI114705B (fi) 2004-12-15
AU2219995A (en) 1995-11-10
MX9603920A (es) 1997-04-30
CZ298196A3 (en) 1997-02-12
RU2149870C1 (ru) 2000-05-27
CN1058708C (zh) 2000-11-22
NO964345D0 (no) 1996-10-11
DE69521310T2 (de) 2002-04-18
CZ284652B6 (cs) 1999-01-13
PT755382E (pt) 2001-11-30
EP0755382B1 (en) 2001-06-13
FI964019A (fi) 1996-10-07
CA2187525A1 (en) 1995-10-26
HU9602747D0 (en) 1996-11-28
FI964019A0 (fi) 1996-10-07
ATE202089T1 (de) 2001-06-15
NO964345L (no) 1996-12-11
WO1995028388A1 (en) 1995-10-26
HU215387B (hu) 1998-12-28
ES2159633T3 (es) 2001-10-16
FI115630B (fi) 2005-06-15
AU700773B2 (en) 1999-01-14
SK131796A3 (en) 1997-05-07
JP3782445B2 (ja) 2006-06-07
NZ283779A (en) 1998-02-26

Similar Documents

Publication Publication Date Title
EP1407768A3 (en) The potassium channel opener retigabine for the treatment of diseases
NL300433I2 (en) Methods and compositions for the treatment of glomerulonephritis.
AUPM672594A0 (en) A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
ZA966240B (en) Methods for treatment of allergic asthma.
AUPM761094A0 (en) Treatment of hides
AU2825295A (en) Method for the treatment, prevention or minimization of hair loss
GR3036482T3 (en) Quinolone derivative for treatment of urinary incontinence
AU628197B2 (en) Agent for the treatment of cast iron melts, process for the production thereof and the use thereof for treating cast iron melts
ZA975489B (en) Device for topical treatment of acne and its method of manufacture.
AU3848797A (en) Process and composition for the antiparasitic treatment of the surroundings of animals
AU6252699A (en) Composition and method for treating allergic diseases
EP0826374A3 (en) Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
AU2790697A (en) Agent for treating allergic dermatitis
AU4882897A (en) Disinfectant composition, particularly for the prevention of dermatitis induced by diapers, and method for its use
ZA974386B (en) New formulation for treatment of thromboembolism.
AU6391199A (en) Composition and method for treating allergic diseases
AU3247995A (en) Treatment of hides
AU7078298A (en) Method for the diagnosis, treatment and prophylaxis of premature ejaculation andcatheter for the diagnosis, treatment and prophylaxis of premature ejaculation
HUT74772A (en) Adjuvant composition, dispersible concentrate, diluted formulation, process for treating vegetation and method for working metal
AU3974597A (en) Composition, process and method for treating grass by foliar application
GB9616332D0 (en) Methods, uses and devices for antimicrobial treatment of mammalian skin
AUPM649094A0 (en) Apparatus for treatment of hides
AUPN904796A0 (en) Method and composition for treatment of ocular diseases
AUPO205496A0 (en) Treatment of hides
HU9400666D0 (en) Plant extract composition for treating injuries of eye, skin and mucous

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100413